Page 41 - D. Cancer biology

Recent technological trend of cancer immunotherapy based on
patent information analysis for R&D planning and strategy

Doyeon Lee *, Keunhwan Kim , and Donkyu Won 3
2
1
1 R&D Investment Analysis Center, Division of Data Analysis, Korea Institute of Science and Technology Information
2 Data Platform Center, Division of Data Analysis, Korea Institute of Science and Technology Information
3 R&D Investment Analysis Center, Division of Data Analysis, Korea Institute of Science and Technology Information
BACKGROUND AIM
In this study, we analyzed the global patent trends of the past 10
Cancer immunotherapy is highly attended treating option in incurable years for cancer immunotherapy to provide a technological
cancer. This therapeutic approach is based on removing cancer cell with landscape in the field of anti-cancer drugs. A total of 8,414 patents
patient's own immune system by inhibiting the immune escaping were categorized in 4 sub-technology fields which include as
characters of cancer cells. Due to its therapeutic effect and relatively low immune checkpoint, immune cell therapy, therapeutic antibody,
side effects in clinical trials targeting various cancers, it has attracted anticancer vaccine. We further analyzed the global patents of
cancer immunotherapy according to year, countries, applicants and
attention as a game changer in the anticancer drug market. sub-technology fields, such as market share, competition intensity.
METHODS and RESULTS

CONCLUSION REFERENCES ACKNOWLEDGEMENTS
These results provide the Advances in cancer immunotherapy 2019- This work was supported by the Korea Institute
of Science and Technology Information (KISTI)
comprehensive data of patent latest trends (Journal of Experimental & granted by the Korean government (MSIT) (No.
information to understand recent Clinical Cancer Research, Stephan K-20-L03-C03-S01) and (No. K-20-L03-C04-S01).
technological trend, and the Kruger, et al.), 2019 Contact information
direction of new R&D on developing Cancer immunotherapy: Pros, cons and Doyeon Lee (Senior Researcher / Ph.D)
the cancer immunotherapy fields. beyond (Biomedicine & Pharmacotherapy, TEL : +82-2-3299-6030, +82-2-3299-6259
ShuzhenTan et al.), 2020 E-mail : dylee@kisti.re.kr